Who makes Efavirenz, Methadone and Tizanidine?

Efavirenz, Methadone and Tizanidine is developed by Indiana University.

What development phase is Efavirenz, Methadone and Tizanidine in?

Efavirenz, Methadone and Tizanidine is in Phase 1.

Last reviewed 2026-05-14 · How we verify

Efavirenz, Methadone and Tizanidine

Indiana University · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	Efavirenz, Methadone and Tizanidine
Sponsor	Indiana University
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Efavirenz, Methadone and Tizanidine CI brief — competitive landscape report
Efavirenz, Methadone and Tizanidine updates RSS · CI watch RSS
Indiana University portfolio CI